AudreaMerchantMD

Psychiatry • Oak Ridge, TN

Physician

Join to view full profile

Dr. Merchant is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Merchant's full profile

Already have an account?

Office
240 W Tyrone Rd
Oak Ridge, TN 37830
Phone+1 865-482-1076

Fax+1 865-481-6166

Education & Training

ECU Health Medical Center/East Carolina UniversityResidency, Internal Medicine/Psychiatry, 1999 - 2003
ECU Health Medical Center/East Carolina UniversityInternship, Internal Medicine, 1998 - 1999
Duke University School of MedicineClass of 1998
University of MichiganPhD, Pharmacology, Howard Hughes Graduate Research Fellowship, 1989 - 1995
University of TampaBS, Chemistry, Full academic scholarship, 1985 - 1989
University of TampaB.S., Major in Chemistry, Minor in Biology, Cum Laude, 1985 - 1989

Certifications & Licensure

TN State Medical License 2012 - 2025
FL State Medical License 2011 - 2022
NC State Medical License 1998 - 2003

Awards, Honors, & Recognition

Graduated with Honors University of Tampa, 1989
Presidential Academic Scholars Award University of Tampa

Publications & Presentations

Journal Articles

Prevention of Fluorodeoxyuridine-Induced Cytotoxicity and DNA Damage in HT29 Colon Carcinoma Cells by Conditional Expression of Wild-Type p53 Phenotype
L.A. Parsels, R.C. Zellars, T.L. Loney, J.D. Parcels, M.F. Clarke, A.K. Merchant, T.S. Lawrence, and J. Maybaum, Molecular Pharmacology, 1/1/1997
Expression of Wild-Type p53 Stimulates an Increase in Both Bax and Bcl-xL Protein content in HT29 Cells
A.K. Merchant, T.L. Loney, and J. Maybaum, Oncogene, 1/1/1997
Dependence of Fluorodeoxyuridine-induced Cytotoxicity and Megabase DNA Fragment Formation on S Phase Progression in HT29 Cells
H.Y. Tang, K.L. Weber, T.S. Lawrence, A.K. Merchant, and J. Maybaum, Cancer Chemotherapy Pharmacology, 1/1/1996
Bcl-2 Inhibits Chemotherapy-Induced Apoptosis in Neuroblastoma
M. Dole, G. Nuñez, A.K. Merchant, J. Maybaum, C.K. Rode, C.A. Bloch, and V.P. Castle, Cancer Research, 1/15/1994
Join now to see all